The role of mutations in p53 in the development of colon cancer is being actively studied, and the suppression of the mutant p53 function via the inhibition of nuclear accumulation is expected to be an effective strategy against malignant progression of colorectal cancer (Nakayama & Oshima, 2019). Here, TP53 is linked to colonic neoplasm.